In addition, we demonstrated the effectiveness of combined FAK/SRC and MEK inhibition in enhancing the response of both resistant and sensitive MPNST cells to MEKis (Figure 7). This evidence concerns the gene MAP2K7 and malignant peripheral nerve sheath tumor.